10 results
10-K
2020 FY
TSHA
Taysha Gene Therapies Inc
3 Mar 21
Annual report
9:00am
require the reporting of information related to drug pricing, state and local laws requiring the registration of pharmaceutical sales representatives … of drug pricing.
The ACA, which was enacted in March 2010, substantially changed the way healthcare is financed by both governmental and private insurers
10-Q
2020 Q3
TSHA
Taysha Gene Therapies Inc
12 Nov 20
Quarterly report
4:27pm
and other healthcare providers, marketing expenditures or drug pricing; state laws that require pharmaceutical companies to comply with the pharmaceutical … the 340B drug pricing program; (iii) increased the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program to 23.1% and 13
424B4
TSHA
Taysha Gene Therapies Inc
25 Sep 20
Prospectus supplement with pricing info
12:00am
transfers of value to physicians and other healthcare providers, marketing expenditures or drug pricing; state laws that require
pharmaceutical companies … programs; (ii) expanded the entities eligible for discounts under the 340B drug pricing program; (iii) increased the statutory minimum rebates
S-1/A
qgw7ejrulzlye4
8 Sep 20
IPO registration (amended)
4:43pm
S-1
uia34kdll
2 Sep 20
IPO registration
5:02pm
DRS
xlyk7unkgkd
3 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next